Biotherapy International

28/07/2025

🌿 Two Types of Mesenchymal Stem Cells — What’s the Difference and What Do We Choose?

We work exclusively with mesenchymal stem cells (MSCs) — but it’s important to understand that they come in two types:

1️⃣ The patient’s own stem cells
2️⃣ Donor stem cells, most often derived from umbilical cord tissue

Both types provide anti-inflammatory and immune-regulating effects — especially after laboratory expansion, which we always perform to enhance their therapeutic activity.

✅ Donor MSCs tend to produce a stronger anti-inflammatory effect at the beginning of treatment, although they are gradually cleared from the body.

✅ The patient’s own MSCs are never rejected and may contribute to tissue regeneration.

We apply special methods to prolong the activity of donor cells in the body, helping extend and strengthen the therapeutic effect.

The choice of cell type depends on the patient’s condition, diagnosis, and treatment goals.

https://ibiotherapy.com/regenerative-medicine/

19/07/2025

🌿 Advanced Immunotherapy for Metastatic Breast Cancer

40-60% of patients with metastatic breast cancer eventually develop resistance to standard treatment methods.

Our therapeutic approaches offer new opportunities for effective treatment even in the most challenging clinical cases.

This treatment is designed for:

• Patients with advanced-stage breast cancer
• Cases where standard treatment isn't working
• Particularly challenging and resistant forms of the disease

This comprehensive approach ensures effective disease control and significantly increases the likelihood of achieving long-term remission.

📞 Book your consultation and get a personalized treatment plan

https://ibiotherapy.com/immunotherapy/breast-cancer/

11/07/2025

❓ Many patients ask: why is cancer treatment so expensive?

But not all cancer immunotherapy is the same — while standard drugs are accessible to many, innovative approaches require significantly more resources.

🌿 We're talking about advanced technologies, strict sterility conditions, and the work of a highly specialized medical team. Professor Slavin speaks openly about what drives the cost — and most importantly, who ultimately has to pay for this treatment.

https://ibiotherapy.com/blog/how-much-does-cancer-immunotherapy-cost/

26/06/2025

❗️ Why wait for cancer to grow stronger?

🌿 Innovative immunotherapy is capable of detecting and eliminating malignant cells before they develop defense mechanisms. This helps prevent drug resistance and effectively stop the disease.

Most importantly, patients may avoid aggressive chemotherapy in the future and preserve their quality of life 🙌

20/06/2025

🌿 Advanced Immunotherapy for Metastatic Melanoma

For 40-60% of metastatic melanoma patients, standard immunotherapy either proves ineffective or loses efficacy over time. Our innovative approach offers hope for patients.

Ideal for patients with:

• Stage 3-4 melanoma requiring intensive treatment
• Progression on standard checkpoint inhibitors
• Resistance to BRAF/MEK therapy
• Interest in the most innovative treatment methods
• Ready to travel abroad for treatment if needed

Learn more ⬇️

https://ibiotherapy.com/immunotherapy/melanoma/

Explore advanced immunotherapy options for metastatic melanoma, including oncolytic virus therapy, cancer vaccines, and others

10/06/2025

🌿 Recovery report from our patient

Wishing them a full recovery! 🙏

29/05/2025

❗️ What if the doctors said, “There’s nothing more we can do”?

Does that mean hope is gone?

Professor Shimon Slavin has spent decades developing and applying innovative treatments — exactly where conventional medicine gives up.

He keeps fighting for his patients, even when others stop.

Watch the full interview ⬇️
https://www.youtube.com/watch?v=KZbuxf6fG9Q

14/05/2025

❗️ He Beat Pancreatic Cancer — Thanks to “Foreign” Immune Cells

Ten years ago, Yamini was given one of the most terrifying diagnoses — pancreatic cancer. The prognosis was extremely poor.

He became one of the first patients in the world to undergo a unique form of immunotherapy using donor lymphocytes — killer cells that activate the body’s immune response.

https://ibiotherapy.com/all-immunotherapy/atack/

05/05/2025

❗Direct Injection of Oncolytic Viruses into the Tumor

In some cases, if imaging shows that a needle can be safely inserted, we use a targeted method: injecting oncolytic viruses directly into the tumor using CT or ultrasound guidance.

🎯 The goal? To activate the immune system right at the tumor site.
This can lead not only to a local immune attack, but also to a systemic response — where the body may begin to fight distant metastases, even if they weren’t treated directly.

👉 Learn more about how oncolytic viruses work:

https://ibiotherapy.com/all-immunotherapy/oncolytic-viruses/

25/04/2025

❗In April 2024, Abass began treatment at our clinic after being diagnosed with brain cancer — diffuse glioma and pilocytic astrocytoma.

He underwent a 15-day course of oncolytic virus therapy (IBDV), administered intravenously and intranasally, at our partner clinic in Kazakhstan. This was followed by three courses of checkpoint inhibitors — a type of immunotherapy that enhances the effect of viral treatment.

We supported Abass every step of the way: helping him find accommodation, providing translation at the clinic, and offering ongoing personal assistance during his stay abroad.

Four months later, a follow-up MRI showed positive results — the tumor had significantly reduced and has not progressed since ☘️

Abass is now preparing for the next round of treatment to fully overcome the disease 💪

In the video: Abass in Kazakhstan right after completing his therapy.

https://ibiotherapy.com/all-immunotherapy/oncolytic-viruses/

23/04/2025

❗️She Said No to Surgery — Netta Beat Brain Cancer

Netta’s journey began in 2010. As a mother of two young children, she began suffering from intense, debilitating headaches. One day, she suddenly lost control of her car while driving. An MRI revealed a malignant brain tumor.

After the surgery, she was diagnosed with anaplastic astrocytoma — an aggressive form of brain cancer that responds poorly to treatment. On average, patients live 2–3 years.

Netta underwent chemotherapy and radiation — and made a firm decision not to give up.

She turned to Biotherapy International, where she was offered a personalized immunotherapy protocol — a treatment designed to activate her immune system to fight the tumor. The therapy worked: remission followed, and for the next five years, the cancer remained inactive.

But then came a setback. The tumor returned — larger and more aggressive.
Doctors at her local hospital urged immediate surgery, warning of a 20% risk of permanent disability. Netta refused.

Instead, she returned to our clinic and began a new phase of treatment: oncolytic virus therapy followed by immunotherapy.

It was her opportunity to avoid a second surgery — and a chance to reclaim her life.

🍀 Today, 15 years after her initial diagnosis, Netta is completely healthy.
She lives a normal life — caring for her children, working, enjoying each day to the fullest, as if cancer were never part of her story.

Netta’s case is the first documented instance of brain cancer being successfully treated with oncolytic viruses and immunotherapy.
No side effects. No repeat surgery.
Just science, resilience, and a bold new approach to treatment.

https://ibiotherapy.com/reviews/cure-brain-cancer-immunotherapy/

21/04/2025

❗ Mesenchymal stem cells (MSCs) are increasingly being used in the treatment of multiple sclerosis and other autoimmune conditions 🍀

But before choosing this type of therapy, it's essential to understand how it works — and whether it's the right option for you.

WHAT TYPES OF STEM CELLS ARE USED FOR MS?

✅ Donor-derived (allogeneic) — obtained from another person, most often from umbilical cord tissue. These cells can reduce chronic inflammation and help regulate immune system function.

✅ Autologous (your own) — harvested from the patient’s own body, typically from bone marrow. These cells not only reduce inflammation but can also turn into oligodendrocytes — the cells that produce myelin, the protective sheath around nerve fibers. This makes them a more promising option for treating multiple sclerosis.

https://ibiotherapy.com/neurological-disorders/multiple-sclerosis/